Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Nature|June 23, 2009
mTOR regulates memory CD8 T-cell differentiationKoichi Araki, Alexandra P Turner, Virginia Oliva Shaffer, et al.
Allergy|December 10, 2019
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itchFlorian Olomski, Victoria Fettelschoss, Sigridur Jonsdottir, et al.
Journal for Immunotherapy of Cancer|September 13, 2022
In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanomaMona O Mohsen, Matthew Heath, Matthias F Kramer, et al.
Scientific Reports|January 20, 2016
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunizationKarl D Brune, Darren B Leneghan, Iona J Brian, et al.
Virology Journal|December 23, 2009
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 proteinRoger R Beerli, Monika Bauer, Nicole Schmitz, et al.
European Journal of Immunology|April 13, 2011
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosisStefan Freigang, Franziska Ampenberger, Gunther Spohn, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2010
Mechanisms of allergen-specific desensitizationChristina Uermösi, Roger R Beerli, Monika Bauer, et al.
Journal of Virology|October 28, 2004
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivoErika Schlaepfer, Annette Audigé, Barbara von Beust, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetesGunther Spohn, Christian Schori, Iris Keller, et al.
Plos One|March 31, 2010
Versatile virus-like particle carrier for epitope based vaccinesAlain C Tissot, Regina Renhofa, Nicole Schmitz, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Nature|June 23, 2009
mTOR regulates memory CD8 T-cell differentiationKoichi Araki, Alexandra P Turner, Virginia Oliva Shaffer, et al.
Allergy|December 10, 2019
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itchFlorian Olomski, Victoria Fettelschoss, Sigridur Jonsdottir, et al.
Journal for Immunotherapy of Cancer|September 13, 2022
In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanomaMona O Mohsen, Matthew Heath, Matthias F Kramer, et al.
Scientific Reports|January 20, 2016
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunizationKarl D Brune, Darren B Leneghan, Iona J Brian, et al.
Virology Journal|December 23, 2009
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 proteinRoger R Beerli, Monika Bauer, Nicole Schmitz, et al.
European Journal of Immunology|April 13, 2011
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosisStefan Freigang, Franziska Ampenberger, Gunther Spohn, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2010
Mechanisms of allergen-specific desensitizationChristina Uermösi, Roger R Beerli, Monika Bauer, et al.
Journal of Virology|October 28, 2004
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivoErika Schlaepfer, Annette Audigé, Barbara von Beust, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetesGunther Spohn, Christian Schori, Iris Keller, et al.
Plos One|March 31, 2010
Versatile virus-like particle carrier for epitope based vaccinesAlain C Tissot, Regina Renhofa, Nicole Schmitz, et al.
Pageof 25